The management of central diabetes insipidus in infancy: Desmopressin, low renal solute load formula, thiazide diuretics

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 4, 2007, Pages 459-469

  Rivkees, Scott A ^a   Dunbar, Nancy ^a   Wilson, Thomas A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Chlorothiazide; DDAVP; Desmopressin; Diabetes insipidus; Infant; Renal solute load; Thiazide; Vasopressin

Indexed keywords

AMILORIDE; CHLOROTHIAZIDE; DESMOPRESSIN; INDOMETACIN; SODIUM; THIAZIDE DIURETIC AGENT; VASOPRESSIN; VASOPRESSIN DERIVATIVE; WATER;

ADIPSIA; ARTIFICIAL MILK; BODY WATER; BODY WEIGHT; CALORIC INTAKE; CHILD CARE; CONCENTRATION (PARAMETERS); DIABETES INSIPIDUS; DRUG ABSORPTION; DRUG DOSAGE FORM COMPARISON; DRUG DOSE INCREASE; DRUG HALF LIFE; FLUID INTAKE; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPERTENSION; HYPERURICEMIA; HYPONATREMIA; INFANT; INFANT FEEDING; INTESTINE BLOOD FLOW; MEDICAL DECISION MAKING; MICTURITION; PATIENT MONITORING; REVIEW; SIDE EFFECT; WATER LOSS;

EID: 34249907542     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.4.459     Document Type: Review

References (50)

1. Baylis PH, Cheetham T. Diabetes insipidus. Arch Dis Child 1998; 79: 84-89.
2. Maghnie M. Diabetes insipidus. Horm Res 2003; 59 (Suppl 1): 42-54.
3. Ghirardello S, Garrè ML, Rossi G, Maghnie M. The diagnosis of children with central diabetes insipidus. J Pediatr Endocrinol Metab 2007; 20: 359-375.
4. Muglia L, Majzoub J. Disorders of the posterior pituitary gland. In: Sperling M, ed. Pediatric Endocrinology. Philadelphia, PA: Saunders, 2002; 289-322.
5. Sands JM, Bichet DG. Nephrogenic diabetes insipidus. Ann Intern Med 2006; 144: 186-194.
6. Fjellestad-Paulsen A, Laborde K, Kindermans C, Czernichow P. Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus. Acta Paediatr 1993; 82: 752-757.
7. Bode HH, Crawford JD, Danon M. Disorders of anti-diuretic hormone homeostasis: diabetes insipidus and SIADH. In: Lifshitz F, ed. Pediatric Endocrinology. New York: Marcel Dekker, 1996; 731-752.
8. Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes. Mol Endocrinol 1997; 11: 1806-1813.
9. Wang LC, Cohen ME, Duffner PK. Etiologies of central diabetes insipidus in children. Pediatr Neurol 1994; 11: 273-277.
10. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, Tinelli C, Gallucci M, Bernasconi S, Boscherini B, Severi F, Arico M. Central diabetes insipidus in children and young adults. N Engl J Med 2000; 343: 998-1007.
11. Maghnie M, Ghirardello S, de Bellis A, di Iorgi N, Ambrosini L, Secco A, de Amici M, Tinelli C, Bellastella A, Lorini R. Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin-cell antibodies and markers of autoimmunity. Clin Endocrinol (Oxf) 2007; 66: 154-156.
12. Bichet DG, Arthus MF, Lonergan M, Hendy GN, Paradis AJ, Fujiwara TM, Morgan K, Gregory MC, Rosenthal W, Didwania A, et al. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest 1993; 92: 1262-1268.
13. Bode HH, Crawford JD. Nephrogenic diabetes insipidus in North America. The Hopewell hypothesis. N Engl J Med 1969; 280: 750-754.
14. Nguyen MK, Nielsen S, Kurtz I. Molecular pathogenesis of nephrogenic diabetes insipidus. Clin Exp Nephrol 2003; 7: 9-17.
15. Bichet DG. Nephrogenic diabetes insipidus. Am J Med 1998; 105: 431-442.
16. Robertson GL. The use of vasopressin assays in physiology and pathophysiology. Semin Nephrol 1994; 14: 368-383.
17. Kim RJ, Malattia C, Allen M, Moshang T Jr, Maghnie M. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations. Pediatr Endocrinol Rev 2004; 2 (Suppl 1): 115-123.
18. Crawford JD, Kennedy GC, Hill LE. Clinical results of treatment of diabetes insipidus with drugs of the chlorothiazide series. N Engl J Med 1960; 262: 737-742.
19. Kirchlechner V, Koller DY, Seidl R, Waldhauser F. Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child 1999; 80: 548-552.
20. Talbot NB, Richie RH, Crawford JD. Metabolic Homeostasis. Cambridge, MA: Harvard University Press, 1959.
21. Pogacar PR, Mahnke S, Rivkees SA. Management of central diabetes insipidus in infancy with low renal solute load formula and chlorothiazide. Curr Opin Pediatr 2000; 12: 405-411.
22. Toumba M, Stanhope R. Morbidity and mortality associated with vasopressin analogue treatment. J Pediatr Endocrinol Metab 2006; 19: 197-201.
23. Friss-Hansen BJ, Holiday MA, Stapelton T. Total body water in children. Pediatrics 1951; 7: 321-357.
24. Gamble JL. Chemical Anatomy, Physiology and Pathology of Extracellular Fluid. Cambridge, MA: Harvard University Press, 1947.
25. Humes HD, Narins RG, Brenner BM. Disorders of water balance. Hosp Pract 1979; 14: 133-145.
26. Hickman RO, Yasuda KE. Fluid therapy. In: Kelley VC, ed. Practice of Pediatrics. Philadelphia, PA: Harper and Row, 1986; 1-29.
27. Wallace WM. Quantitative requirements of infant and child for water and electrolyte under varying conditions. Am J Clin Path 1953; 23: 1133-1147.
28. McCrory WW. The excretory system. In: Cooke RE, Levin S, eds. The Biological Basis of Pediatric Practice. New York: McGraw Hill, 1968; 989-1002.
29. Weitzman RE, Kleeman CR. The clinical physiology of water metabolism. Part I: The physiologic regulation of arginine vasopressin secretion and thirst. West J Med 1979; 131: 373-400.
30. Bichet DG. Vasopressin receptors in health and disease. Kidney Int 1996; 49: 1706-1711.
31. Weitzman RE, Kleeman CR. The clinical physiology of water metabolism. Part III: The water depletion (hyper-osmolar) and water excess (hyposmolar) syndromes. West J Med 1980; 132: 16-38.
32. Crawford JD, Frost LR. A study of interphase in experimental diabetes insipidus. Endocrinology 1963; 72: 677-683.
33. Metcoff J. Regulation of the body fluids. In: Cooke RE, Levin S, eds. The Biological Basis of Pediatric Practice. New York: McGraw Hill, 1968; 95-143.
34. Spevak PJ, Bode HH. Comparison of therapeutic modalities of diabetes insipidus (DI) in infancy. Pediatr Res 1983; 17: 357A (Abst).
35. Robertson GL, Harris A. Clinical use of vasopressin analogues. Hosp Pract (Off Ed) 1989; 24: 114-118.
36. Chanson P, Jedynak CP, Dabrowski G, Rohan JE, Bouchama A, de Rohan-Chabot P, Loirat P. Ultralow doses of vasopressin in the management of diabetes insipidus. Crit Care Med 1987; 15: 44-46.
37. Fjellestad-Paulsen A, Tubiana-Rufi N, Harris A, Czernichow P. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin. Acta Endocrinol (Copenh) 1987; 115: 307-312.
38. Fjellestad A, Czernichow P. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP). Acta Paediatr Scand 1986; 75: 605-610.
39. Cohen C, Rice EN, Thomas DE, Carpenter TO. Diabetes insipidus as a hallmark neuroendocrine complication of neonatal meningitis. Curr Opin Pediatr 1998; 10: 449-452.
40. Blanco EJ, Lane AH, Aijaz N, Blumberg D, Wilson TA. Use of subcutaneous DDAVP in infants with central diabetes insipidus. J Pediatr Endocrinol Metab 2006; 19: 919-925.
41. Crigler JF Jr. Commentary: On the use of pitressin in infants with neurogenic diabetes insipidus. J Pediatr 1976; 88: 295-296.
42. Fjellestad-Paulsen A, Crosnier H, Czernichow P. Central diabetes insipidus in the very young child. Treatment with oral desmopressin. Arch Fr Pediatr 1988; 45: 787-790.
43. Yarber B, Wood B. Early diagnosis and treatment of diabetes insipidus in a newborn infant: a case study. Neonatal Netw 1992; 11: 17-20.
44. Laraugh JH. The use of chlorothiazide. Ann NY Acad Sci 1958; 71: 409-419.
45. Loffing J. Paradoxical antidiuretic effect of thiazides in diabetes insipidus: another piece in the puzzle. J Am Soc Nephrol 2004; 15: 2948-2950.
46. Crawford JD, Kennedy GC. Chlorothiazide in diabetes insipidus. Nature 1959; 183: 891-892.
47. Mizuno H, Fujimoto S, Sugiyama Y, Kobayashi M, Ohro Y, Uchida S, Sasaki S, Togari H. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin. Horm Res 2003; 59: 297-300.
48. Libber S, Harrison H, Spector D. Treatment of nephrogenic diabetes insipidus with prostaglandin synthesis inhibitors. J Pediatr 1986; 108: 305-311.
49. Wise-Faberowski L, Soriano SG, Ferrari L, McManus ML, Wolfsdorf JI, Majzoub J, Scott RM, Truog R, Rockoff MA. Perioperative management of diabetes insipidus in children [corrected]. J Neurosurg Anesthesiol 2004; 16: 14-19.
50. Darrow DC, Yannet H. Changes in distribution of body water accompanying increase and decrease in extracellular electrolyte. J Clin Invest 1935; 266-281.